Brain tumor tissue analysis for glioma diagnosis
Part of Cancer clinical trials.
This study looks at the chemicals and genes in brain tumors called gliomas to find better ways to diagnose and treat them. People with a brain mass that needs surgery may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a brain mass or tumor seen on an MRI or PET scan
- You are scheduled for brain surgery to remove the mass
- You can understand and sign a consent form
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether brain scans (MRI, PET/CT) can help predict the genetic makeup of glioblastoma, without needing more tissue samples. If you join, you'll get advanced imaging to better understand your tumor and guide future treatment decisions.
This study analyzes tissue and health-related biological data from people with glioblastoma to learn what’s happening in the tumor. The results may help improve future ways to understand and treat glioblastoma using advanced computer analysis.
This trial uses a special MRI scan to study the genetics of gliomas (a type of brain tumor). It may help doctors better understand your tumor and choose the right treatment. You can join if you have a suspected or confirmed low- or high-grade glioma that still has a measurable tumor after surgery.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
This trial is for people with glioma who have tumor tissue or blood samples stored. It uses artificial intelligence to analyze these samples and find the best treatment. You might be eligible if you are at least 18 years old and have had a glioma diagnosis with tissue available for study.
This study is collecting information about people in Brazil who have been diagnosed with a type of brain tumor that has an IDH mutation. It aims to better understand the disease and support future research, without giving new treatments.
Hear when a new IDH Wildtype Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.